Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2017 07:00 ET | Source: Curis, Inc

Curis Reports Second Quarter 2017 Financial Results

LEXINGTON, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates...
July 26, 2017 07:00 ET | Source: Curis, Inc

Curis to Release Second Quarter 2017 Financial Results and Hold Conference Call on August 3, 2017

LEXINGTON, Mass., July 26, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the...
July 05, 2017 16:30 ET | Source: Curis, Inc

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LEXINGTON, Mass., July 05, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates...
June 01, 2017 12:07 ET | Source: Curis, Inc

UPDATE - Curis to Present at the Jefferies Healthcare Conference

LEXINGTON, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics...
June 01, 2017 07:00 ET | Source: Curis, Inc

Curis to Present at the Jefferies Healthcare Conference

LEXINGTON, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
May 25, 2017 07:00 ET | Source: Curis, Inc

Curis Announces Presentations Related to CA-170 and CUDC-907 at 2017 ASCO Annual Meeting

LEXINGTON, Mass., May 25, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
May 04, 2017 07:00 ET | Source: Curis, Inc

Curis Reports First Quarter 2017 Financial Results

LEXINGTON, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for...
April 28, 2017 14:04 ET | Source: Curis, Inc

Curis to Release First Quarter 2017 Financial Results and Hold Conference Call on May 4, 2017

LEXINGTON, Mass., April 28, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the...
April 05, 2017 07:00 ET | Source: Curis, Inc

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LEXINGTON, Mass., April 05, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates...
March 30, 2017 13:30 ET | Source: Curis, Inc

Curis to Present Preclinical Data on IRAK4 Kinase Inhibitor CA-4948 at AACR Annual Meeting

LEXINGTON, Mass., March 30, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates...